Project Grant HT94252310991
Award Date
9/30/23
Completion Date
9/29/27
Dollars Obligated
$4.5M
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Houston, TX 77030, USA
Similar Awards
The University of Texas Health Science Center at Houston (UTHealth) was awarded a $769,578 Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to conduct research on "ENHANCING BIOENERGETICS AS A STRATEGY TO IMPROVE OUTCOME AFTER MILD TRAUMATIC BRAIN INJURY". The award, which runs from May 1, 2024 to April 30, 2027, will support UTHealth's efforts to advance scientific knowledge and develop innovative treatments for...
The Department of Defense's Military Medical Research and Development program (CFDA 12.420) has awarded a $7,693,599 project grant to the University of Texas Health Science Center at Houston (UTHealth). The award, with a period of performance from Sep 15, 2023 to Sep 14, 2027, will fund research to study "Trauma-Induced Coagulopathy and the Blood-Brain Barrier: Impact of Resuscitation." As the prime grantee, UTHealth will leverage its expertise in biomedical research, clinical...
The University of Texas Health Science Center at San Antonio (UTHSCSA) was awarded a $6,133,100 Project Grant by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program. The grant supports a 4-year research project to develop and validate personalized treatment models for persistent headaches attributable to mild traumatic brain injury in U.S. military service members and veterans. The research includes specifying and validating patient-centered models...
The University of Texas Health Science Center at San Antonio (UTHSCSA) was awarded a $493,610 Project Grant from the Department of Defense's Military Medical Research and Development (CFDA 12.420) program to conduct a randomized clinical trial utilizing crisis response planning for suicide prevention in military personnel with traumatic brain injury. The grant, awarded on August 1, 2024, will support this research project over a 3-year period, with a final completion date of July 31, 2027. As...
This federal Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) provides $1,559,997.00 to the University of Texas Health Science Center at Houston (UTHealth) to conduct a pharmacology and efficacy study of a novel blood-brain barrier (BBB)-permeable agent for the treatment of breast cancer brain metastases. The research project aims to advance disease prevention, diagnosis, treatment, and management through basic, applied,...
The University of Texas Health Science Center at San Antonio (UTHSCSA) was awarded a $131,685 Project Grant from the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) federal grant program. The grant, titled "TARGETED AUDITORY PLASTICITY TRAINING TO IMPROVE CENTRAL HEARING IN MILD TBI", will support research to develop innovative approaches for improving central hearing in individuals with mild traumatic brain injury. The grant has a performance...
The University of Texas Health Science Center at Houston (UTHSC-H) was awarded a $702,000 Project Grant from the Department of the Army Medical Command under the Military Medical Research and Development program to support research on a novel modality to target breast cancer stem cells. The three-year award, effective September 1, 2022 through August 31, 2025, will fund the development of innovative medical solutions targeting breast cancer stem cells through basic, applied, and advanced...
The University of Texas Health Science Center at Houston (UTHealth) received a $3,845,822 Project Grant award from the Defense Health Agency (CFDA 12.420 - Military Medical Research and Development) to conduct a comparative effectiveness study on transdiagnostic behavior therapy versus treatment-as-usual for adjustment disorder following traumatic event exposure. The award runs from July 1, 2024 to June 30, 2028. The federal grant supports innovative biomedical research initiatives aimed at...
The Defense Health Agency awarded a $725,000 project grant to The University of Texas Southwestern Medical Center in Dallas, Texas, for research under the Military Medical Research and Development program. The three-year award beginning June 15, 2023, will support research into glutamine-targeted therapies to prevent traumatic heterotopic ossification. As the parent organization, the University of Texas System will provide research support services through this subaward. The Military Medical...
The University of Texas Health Science Center at Houston (UTHealth) received a $777,586 Project Grant award from the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) federal grant program. The award, with a performance period from September 30, 2024 to September 29, 2027, will fund the "Stress Inoculation Training (SIT): An Evidence-Driven, Military-Aligned Psychological Performance and Health Sustainment Prototype" research project. The project...